Vertex Pharmaceuticals
VRTX
VRTX
521 hedge funds and large institutions have $25.8B invested in Vertex Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 85 funds opening new positions, 186 increasing their positions, 185 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
521
Holders Change
+38
Holders Change %
+7.87%
% of All Funds
12.99%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.2%
New
85
Increased
186
Reduced
185
Closed
38
Calls
$257M
Puts
$259M
Net Calls
-$2.22M
Net Calls Change
+$3.68M
Top Buyers
| 1 |
BlackRock
New York
|
+$2.03B |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$311M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$122M |
| 4 |
HM
HealthCor Management
New York
|
+$112M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$109M |
Top Sellers
| 1 |
Capital World Investors
Los Angeles,
California
|
-$312M |
| 2 |
JPMorgan Chase & Co
New York
|
-$135M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$135M |
| 4 |
UBS AM
Chicago,
Illinois
|
-$95.1M |
| 5 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$90.3M |
